@article{48572,
      recid = {48572},
      author = {D'Agostino, Lorena M., and Tiraboschi, Lorenzo, and  Torrisi, Salvatore,},
      title = {European patent opposition outcomes in biotechnology.},
      pages = {1 volume.},
      abstract = {Oppositions to patent grants are a means to attack  competitors and protect a firm's own patent portfolio.  Extant literature has analyzed the determinants of  oppositions, while the drivers of opposition outcomes are  less known. We study 290 EPO biotech patent oppositions  filed in 2012–2019. There are three possible outcomes of  opposition proceedings: patent revocation, patent  amendment, and opposition rejection. We find that opponents  who know the patent's technology are more likely to obtain  a patent revocation, while opponents who compete in the  product market with the patent owner are more likely to  receive a rejection.},
      url = {http://tind.wipo.int/record/48572},
      doi = {https://doi.org/10.1016/j.wpi.2023.102185},
}